Search Results 1-10 of 1425 for %EC%B0%BD%EC%9B%90%EC%B6%9C%EC%9E%A5%EB%A7%8C%EB%82%A8%EF%BC%88KaKaoTalk:ZA31%EF%BC%89%EB%B6%80%EC%82%B0%EC%B6%9C%EC%9E%A5%EC%95%88%EB%A7%88,%EB%B6%80%EC%82%B0%EC%B6%9C%EC%9E%A5%EC%B9%B4%ED%86%A1,%EB%B6%80%EC%82%B0%EC%BD%9C%EA%B1%B8,%EB%B6%80%EC%82%B0%EC%98%A4%ED%94%BC,%EB%B6%80%EC%82%B0op

  2. ... 8 unit-32 unit/0.5 mL injection suspension ... 90 mg tablet,23.09 637000000,536430608,calcium ... 80 mg tablet,9.11 637000000,378512301,sotaloL 80 ...

  3. Genetic Expression in Osteolysis, Infection, Arthrofibrosis & Metal Reactions in THA & TKA: A Microarray Analysis to Characterize Individual Host Response to the Molecular Mechanisms of Loosening and Arthrofibrosis - Mayo Clinic

    This study is being conducted to determine gene and protein expression profiles (i.e. which genes and proteins are turned off and on) of those with a ...

  4. Monitoring Body Composition Changes in High Risk Patients for Pancreatic Cancer (PDAC) - Mayo Clinic

    About this study. The purpose of this research is to monitor body composition changes with wearable devices in patients who have been identified as high ...

  5. PK and Safety of Paclitaxel Injection Concentrate for Nano-dispersion Alone and in Carboplatin Combination - Mayo Clinic

    Part B will start upon completion of Part A and will use the standard '3+3' dose-escalation design to determine the MTD and recommend phase II dose of PICN ...

  6. Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation - Mayo Clinic

    Recent reports have identified a specific oncogenic mutation L265P of the MYD88 gene in approximately 30% of the patients with the activated B-cell (ABC) type ...

  7. Randomized Study of Topical Alicaforsen Enema in Antibiotic Refractory Pouchitis - Mayo Clinic

    At the Baseline visit (Day 1) eligible subjects will be randomised on a 1:1 basis to either a) 240 mg alicaforsen enema or b) matching placebo. Study drug will ...

  8. A Study for Subjects Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Publications - Amer N. Kalaaji, M.D. - Mayo Clinic

    Tekin B, Johnson EF, Wieland CN, Gibson LE, Camilleri MJ, Kalaaji AN, Comfere NI, Peters MS, Lehman JS. Histopathology of autoimmune bullous dermatoses: ...

  10. National Center for Data to Health CD2H.